Authors





Elham Hatef, MD, MPH

Latest:

Annual Diabetic Eye Examinations in a Managed Care Medicaid Population

We assessed challenges and barriers to annual diabetic eye examinations for a managed care Medicaid population and make recommendations to improve population-level screening.


Alessandro Filippi, MD

Latest:

Assessment and Potential Determinants of Compliance and Persistence to Antiosteoporosis Therapy in Italy

This analysis of antiosteoporosis therapy shows that 75% of patients have inadequate drug coverage and that adherence is strongly associated with age and administration regimen.


Jeff Shafiroff, PhD

Latest:

Switching from Multiple Daily Injections to CSII Pump Therapy: Insulin Expenditures in Type 2 Diabetes

The effect of switching from multiple daily insulin injections to an insulin pump on insulin and other diabetic drug expenditures in type 2 diabetes.


Alan H. B. Wu, PhD

Latest:

Antiquated Tests Within the Clinical Pathology Laboratory

Physicians and laboratorians must work to reduce use of antiquated clinical laboratory tests.


Richard L. Bauer, MD

Latest:

An Intervention for VA Patients With Congestive Heart Failure

An intervention of variable intensity for congestive heart failure showed some improvements but no survival effect, suggesting a tradeoff between intervention cost and intensity and survival benefit.


Alexandra Brown, BS

Latest:

5-ASA to Sulfasalazine Drug Switch Program in Patients With Ulcerative Colitis

A 5-aminosalicylic acid (5-ASA) drug switch program switching from 5-ASA to sulfasalazine was instituted for insured patients with ulcerative colitis. Unanticipated barriers limited the number of patients who switched, but significant cost savings were still obtained.


Joseph Rubin, MD

Latest:

Development of a Multidisciplinary, Multicampus Subspecialty Practice in Endocrine Cancers

The development of subspecialty tumor groups for uncommon malignancies represents an effective approach to building experience, increasing patient volumes and referrals, and fostering development of increased therapeutic options and clinical trials for patients afflicted with otherwise historically neglected cancers.




Matthew Zack, MD

Latest:

A Health Plan's Investigation of Healthy Days and Chronic Conditions

Linking administrative claims to health-related quality of life measured in Healthy Days provides a new vision into the health of populations.


Wenjun Zhong, PhD

Latest:

Physician Practice Variation Under Orthopedic Bundled Payment

This study demonstrates that variation reduction is an important, but not requisite, component of organizational success under orthopedic bundled payment.



Mehdi Najafzadeh, PhD

Latest:

Economic Value of Pharmacist-Led Medication Reconciliation for Reducing Medication Errors After Hospital Discharge

The results of this simulation model suggest that implementing a pharmacist-led medication reconciliation intervention at hospital discharge could be cost-saving compared with usual care.


Sarah L. Cutrona, MD, MPH

Latest:

Understanding Suboptimal e-Consult Requests: Lessons From the VA

US Department of Veterans Affairs (VA) clinicians’ perspectives on what constitutes a good e-consult and why suboptimal e-consult requests occur contain broadly applicable lessons for other health systems.



Mynti Hossain, MPP

Latest:

Incorporating Health IT Into Primary Care Transformation

Longitudinal evaluation of an advanced primary care reform effort found some improvements in health information technology (IT) offerings and use as well as opportunities to improve future collaboration.



M. Susan Ridgely, JD

Latest:

Trends in the Use of Clinical Decision Support by Health System–Affiliated Ambulatory Clinics in the United States, 2014-2016

Use of clinical decision support (CDS) in ambulatory clinics is increasing but remains modest. The CDS function with the greatest use is basic medication screening, which increased from 52% of clinics nationally in 2014 to 61% in 2016.



Deanna Hertz, MHEcon

Latest:

The Budget Impact of Cervical Cancer Screening Using HPV Primary Screening

This study assesses the clinical and economic implications from a payer perspective of human papillomavirus genotyping for cervical cancer screening in comparison with existing practices.


Catherine E. Cooke, PharmD

Latest:

Impact of Formulary Restrictions on Medication Intensification in Diabetes Treatment

Formulary restrictions on brand name noninsulin antihyperglycemic drugs have little impact on treatment intensification patterns among low-income patients with diabetes in Medicare Part D.




Joshua T. Cohen, PhD

Latest:

Multiple Chronic Conditions in Type 2 Diabetes Mellitus: Prevalence and Consequences

This study's findings showed that diabetes care remained suboptimal among many patients with multiple chronic conditions and that patient outcomes varied by multimorbidity profile.


Elizabeth Cerceo, MD

Latest:

Discharge Before Noon: Is the Sun Half Up or Half Down?

Discharge before noon was associated with longer length of stay in patients with medical diagnoses and shorter length of stay in surgical patients.



Sarah E. Tom, PhD

Latest:

Placement of Selected New FDA-Approved Drugs in Medicare Part D Formularies, 2009-2013

There is significant heterogeneity in formulary placement and restrictions on new drug approvals in the Part D marketplace.

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo